NEW YORK, July 2, 2014 /PRNewswire/ --
Today, Analysts Review released its analysts' notes regarding Dupont E I De Nemours & Co (NYSE: DD), Monsanto Company (NYSE: MON), Syngenta AG (NYSE: SYT), American Vanguard Corporation (NYSE: AVD) and Sociedad Quimica y Minera de Chile SA (NYSE: SQM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4345-100free.
--
Dupont E I De Nemours & Co Analyst Notes
On June 18, 2014, Dupont E I De Nemours & Co (DuPont) announced that DuPont Protection Technologies has sold one million bullet-resistant vests made with DuPont Kevlar XP globally, since the material was launched in 2008. Marking the milestone, the Company presented an award to the Republic of Korea Army, the recipient of the millionth vest. "The tremendous demand for Kevlar® XP' since its launch has been remarkable, but not surprising, as this advanced material helps enable manufacturers to challenge the boundaries of design and for us to continue our legacy of market-shaping innovation today and in the future," said Jeroen B. Jacobs, Global Marketing Director of DuPont Life Protection. The full analyst notes on DuPont are available to download free of charge at:
http://www.analystsreview.com/Jul-02-2014/DD/report.pdf
--
Monsanto Company Analyst Notes
On June 26, 2014, Monsanto Company (Monsanto) announced the pricing of $4.5 billion aggregate principal amount of fixed rate senior notes. The Company informed that the senior notes include $500 million in senior notes maturing in 2017 with an interest rate of 1.150%; $500 million in senior notes maturing in 2019 with an interest rate of 2.125%; $500 million in senior notes maturing in 2021 with an interest rate of 2.750%; $750 million in senior notes maturing in 2024 with an interest rate of 3.375%; $500 million in senior notes maturing in 2034 with an interest rate of 4.200%; $1 billion in senior notes maturing in 2044 with an interest rate of 4.400%; and $750 million in senior notes maturing in 2064 with an interest rate of 4.700%. Monsanto expects to use the proceeds from the offering, proceeds from the issuance of up to approximately $1.2 billion of commercial paper, as well as available cash, to fund the $6 billion accelerated portion of the Company's share repurchase programs and for other general corporate purposes. The full analyst notes on Monsanto are available to download free of charge at:
http://www.analystsreview.com/Jul-02-2014/MON/report.pdf
--
Syngenta AG Analyst Notes
On June 17, 2014, Syngenta AG (Syngenta) announced a partnership with Anheuser-Busch InBev (AB InBev) to secure the sourcing of high-quality malting barley. Under the agreement, growers will have access to Syngenta malting barley varieties as well as training and advice on agronomy and sustainable farming practices. "We wish to keep barley relevant and interesting for growers by helping them develop their business in a qualitative, sustainable and profitable way. We work with them towards achieving a better yield - investing in the development of improved varieties while providing access to high quality seeds, the latest technology and expert advice from skilled agronomists. This is part of our dream to be the Best Beer Company Bringing People Together For a Better World. As we work with more than 15,000 growers through longstanding barley programs in the United States, Canada, Mexico, Brazil, Uruguay, Argentina, China and Russia, we look forward to turning this new project into a shared success that we can scale," said Tony Milikin, Chief Procurement Officer of AB InBev. The first phase of the partnership is scheduled to take place in Argentina and will involve 160 growers covering 14,000 hectares. The full analyst notes on Syngenta are available to download free of charge at:
http://www.analystsreview.com/Jul-02-2014/SYT/report.pdf
--
American Vanguard Corporation Analyst Notes
On June 9, 2014, the Board of Directors of American Vanguard Corporation (American Vanguard) has declared a $0.05 cash dividend. The dividend is payable on July 17, 2014 to shareholders of record as of July 3, 2014. The full analyst notes on American Vanguard are available to download free of charge at:
http://www.analystsreview.com/Jul-02-2014/AVD/report.pdf
--
Sociedad Quimica y Minera de Chile SA Analyst Notes
On June 26, 2014, Sociedad Quimica y Minera de Chile SA (SQM) announced that it has agreed to submit for the shareholders' approval, at the Extraordinary General Shareholder Meeting on July 7, 2014, the payment of an eventual dividend of c. $0.87 per share to be charged against SQM retained earnings. The Company informed that the eventual dividend is to be paid and distributed to SQM shareholders who are registered in the respective Registry by the fifth business day preceding the day on which the dividend is to be paid. The full analyst notes on SQM are available to download free of charge at:
http://www.analystsreview.com/Jul-02-2014/SQM/report.pdf
--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com .
5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com .
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review
